Monday, 23 October 2017

New diabetes drug may also treat obesity

Test subjects lost an average of 5 kg (11 lb) over 12 weeks, when taking semaglutide

Semaglutide is a compound that's already being developed as a treatment for diabetes, by Danish pharmaceutical company Novo Nordisk. According to a new study conducted by scientists from the University of Leeds, however, it may serve another valuable purpose – it could greatly aid the obese is losing weight.

.. Continue Reading New diabetes drug may also treat obesity

Category: Health & Wellbeing

Tags: Related Articles:

from New Atlas http://ift.tt/2yE8dmL

No comments:

Post a Comment